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Available online 6 January 2016We report here the generation of human iPS cell line UKKi009-A from dermal fibroblasts of a patient carrying
heterozygous mutation c.3035-3045delTCCCTCGATGC, p.Leu1012Pro (fs*55) in KCNH2 gene leading to long QT
syndrome type 2 (LQT2). We used the Sleeping Beauty transposon-based plasmids expressing OSKM along
with microRNAs 307/367 to reprogram the fibroblasts. The iPS cells possess pluripotent stem cell characteristics
and differentiate to cell lineages of all three germ layers. This cell line can serve as a source for in vitromodeling of
LQT2. This cell line is distributed by the European Collection of Authenticated Cell Cultures (ECACC).
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).O
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The human iPSC linewas generated by reprogramming of fibroblasts
cultured from skin biopsy of a 32 year old patient suffering from LQT
syndrome Type 2 (LQT2). LQT syndrome is a medical condition, either
genetic or acquired, described after its characteristic electrocardiogram
showing a prolonged cardiac repolarization phase resulting in a long QT
interval. The clinical symptoms of LQTS include palpitations, syncope,
seizures leading to sudden cardiac death. The patient carried a heterozy-
gousmutation in KCNH2gene c.3035_3045delTCCCTCGATGC leading to
amino acid frame shift beginning at Leucine 1012 (p.Leu1012Pro, fs*55).
Fibroblasts were reprogrammed by transposition of OCT4, SOX2, KLF4
and c-MYC (OSKM) andmiRNA302/367 expression cassettes mobilized
by the SB100X hyperactive transposase (Grabundzija et al., 2013). The
reprogramming was performed on murine embryonic fibroblast
(MEFs) in the presence of valproic acid and vitamin C for 7 days after
transfection. After isolation and initial expansion, the iPS cells were
maintained in a feeder-free system on vitronectin-coated plates increativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of human iPS cell lineUKKi009-A. A.Morphology of iPS cell colonies as observed by brightfieldmicroscopy (left image: 10×, right image: 32×). B. Immunostaining
for OCT4, NANOG, TRA-1-80 and SSEA4 showing the iPS colonies uniformly expressing themarkers. C. Expression of pluripotent stem cell markers TRA-1-80 and SSEA4 on the surface of
UKKi009-A iPS cells as measured by flow cytometry. D. Assessment of pluripotency of iPS cells by RT-qPCR analysis of expression of indicated germ layer-specific transcripts at day 14 of
differentiation compared against undifferentiated cells as a control using the ΔΔCt method. E. RT-PCR showing absence of transgenes SOX2 and c-MYC (left panel) and OCT4 and KLF4
(right panel) expression in iPS cells. Plasmid encoding OSKM cassette was used as a positive control. Arrows indicate the expected band size (1848 bp and 1364 bp for left and right
panel, respectively). M = DNA-size marker. F. DNA sequence showing the presence of mutation c.3035-3045delTCCCTCGATGC in the KCNH2 gene of patient-derived dermal
fibroblasts (hDFs) and UKKi009-A iPS cells derived from them. The nucleotide sequence indicated beneath the sequencing chromatogram is the NCBI Reference Sequence:
XM_011516185.1. G. Single nucleotide polymorphism (SNP) genotyping reveals identity of UKKi009-A iPS cells with NP0011 patient-derived hDFs abut not with hDFs derived from an
unrelated donor NP0022.
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human embryonic stem (ES) cells (Fig. 1A) and expressed endogenous
self-renewal genes OCT4, NANOG and the pluripotent stem cell markers
TRA-1-80 and SSEA4 at the protein level as demonstrated by immuno-
cytochemistry (Fig. 1B) and flow cytometry (Fig. 1C). The pluripotency
was further demonstrated in vitro by embryoid body (EB)-based differ-
entiation to endodermal, mesodermal and ectodermal cell lineages
(Fig. 1D). Cardiac differentiation was confirmed by identification of
spontaneously beating cells (Supplemental video 1). This iPS cell line
did not express transcripts of exogenous reprogramming factors as
shown by semi-quantitative RT-PCR (Fig. 1E). The identity of the
UKKi009-A iPS cell line with parental fibroblasts was confirmed by
identification of the disease-associated mutation in the KCNH2 gene
by DNA sequencing (Fig. 1F), SNP genotyping (Fig. 1G) and short
tandem repeat (STR) analysis (Fig. 2). Molecular karyotyping revealed
a normal female karyotype (Fig. 3). The cell line was also confirmed to
be free of mycoplasma and viral (HIV-1, HCV and HBV) sequences.
2. Materials and methods
Human dermal fibroblasts (hDFs)were isolated from the skin biopsy
of the patient and cultured in human fibroblast culture medium
[Dulbecco'smodified Eaglemedium (DMEM)-GlutaMAX supplemented
with 10% fetal bovine serum (FBS), 1% non-essential amino acids
(NEAA), 100 U/mL penicillin, 100 μg/mL streptomycin and 100 μM β-
mercaptoethanol (β-ME)]. Reprogramming was achieved by transfectinghDFs with plasmids expressing SB100× transposase, OKSM-mCherry,
andmicroRNA 307/367 as described in (Grabundzija et al., 2013). Briefly,
3 × 106 hDFs were transfected with 3 μg of SB-OKSM, 1 μg SB100× and
1 μg of microRNA plasmid using Neon Transfection device and a 100 μL
Neon Tip according to the manufacturer's instructions (ThermoFischer
Scientific). Cells were then cultured in human fibroblast culture medium
for the first 7 days. Later, the cells were re-plated on irradiated MEFs and
cultured in reprogramming medium (DMEM/F-12 + GlutaMAX supple-
mented with 20% KnockOut Serum Replacement (KOSR), 8 ng/mL basic
fibroblast growth factor (bFGF), 1% NEAA, and 100 μM β-ME) containing
vitamin C (50 μg/ml) and valproic acid (1 mM) at 37 °C in normoxic con-
ditions and5%CO2. The cellswere treatedwith smallmolecules for 7 days.
Later, the cells were cultured on MEFs in reprogramming media without
small molecules until iPS cell colonies appeared which were then picked
and cultured. Each picked clone was expanded on MEFs in human iPS
cell medium (DMEM/F-12 + GlutaMAX supplemented with 20% KOSR,
1% NEAA, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μM β-ME
and 10 ng/ml bFGF) and later adapted to culture on vitronectin in E8
medium. iPS cell culture was repeatedly checked for mycoplasma
contamination using MycoAlert before making frozen stocks.
3. In vitro differentiation
Media was removed and the cells were washed with PBS. TrypLE
was added for 3 min. DMEM containing 20% FCS was added to
quench the TrypLE. Cells were centrifuged at 300 ×g for 3 min and
Fig. 2. Confirmation of genetic identity of UKKi009-A iPSC line with the corresponding patient-derived somatic cells. Microsatellite analysis shows matching profiles of short tandem
repeats (STR) amplified from a genomic DNA of UKKi009-A iPS cells and NP0011 patient-derived keratinocytes.
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gies) containing 10 μM Rock inhibitor at 30,000 cells per ml. 100 μl
was then added to each well of a U-bottom 96 well plate and centri-
fuged at 300 ×g for 3 min. The plates were placed in an incubator at
37 °C, 5% CO2. EB's formed overnight. Samples were collected at dayFig. 3.Molecular karyotype of UKKi009-A iPS cells. SNP genoty14. RNA was extracted using Maxwell RSC machine and kit, according
to manufactures instructions (Promega). Three biological replicates
were carried out with one passage between each experiment. Direct-
ed cardiac differentiation was performed according to (Lian et al.,
2013).ping shows that iPS cells have a normal female karyotype.
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cDNAwas produced using a High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems) according to manufacturer's instructions
and analyzed with gene-specific probes (Applied Biosystems) by
standard methods and run on Quantstudio thermocycler. For assess-
ment of cell line pluripotency each differentiated sample was compared
against its undifferentiated counterpart as a normalized control using
the ΔΔCt method, to give relative quantitation (RQ) values using
GAPDH and ACTB as reference genes.
5. Semi-quantitative RT-PCR
Total RNAwas isolated using TRIzol Reagent from confluent growing
cells. DNase I-treated total RNA (500 ng) was reverse-transcribed using
Superscript II RTase and random hexamers (Life Technologies). cDNA
was diluted 1:4 with sterile tri-destilled water and 5 μl were amplified
using JumpStart™ RedTaq ReadyMix™ PCR Reaction Mix (Sigma).
Negative controls were generated in RT reactions in which all reaction
components were included except RTase. Reactions were terminated
at the exponential phase of amplification and products were analyzed
by agarose gel electrophoresis.
6. Immunocytochemistry
Undifferentiated iPS cellswere fixed at 80% confluencywith 4% para-
formaldehyde (PFA), permeabilizedwith 0.1% Triton X-100 and blocked
with 5% FBS. The cells were then stained overnight at 4 °C with primary
antibodies specific for OCT4 (Santa Cruz Biotechnology, Cat. No.
Sc-5279, 1:100), NANOG (R&D Systems, Cat. No. AF1997, 1:100) TRA-
1-80 (Santa Cruz, Cat. No. Sc-21706, 1:200) and SSEA4 (Santa Cruz,
Cat. No. Sc-21704, 1:800). Samples were visualized after staining with
Alexa Fluor 488- or Alexa Fluor 555-conjugated secondary antibodies
(Life Technologies) for 1 h at room temperature. Nuclei were counter-
stained with Hoechst 33342. Samples were embedded in ProLong Gold
Antifade Reagent (Life Technologies) and observed on Axiovert Micro-
scope (Carl-Zeiss Microimaging, Oberkochen, Germany) equipped with
the image processing software Axiovision 4.5.
7. Flow cytometry
Cells were dissociated with Trypsin/EDTA and incubated for 30 min
at 4 °C with Alexa Flor 555-conjugated antibodies against cell surface
markers TRA-1-80 and SSEA4. Alexa Flor 555-conjugated mouse IgM
and IgG antibodies served as isotype controls for TRA-1-80 and SSEA4,respectively. Detection of labeled cells was accomplished on Attune®
Acoustic Focusing Cytometer (Applied Biosystems) using Attune®
Cytometric Software.
8. Microsatellite analysis
Genotype analysis of cell lines was performed using 6 highly infor-
mative microsatellite markers. Fluorescently labeled PCR products
were electrophoresed and detected on an automated 3730 DNAAnalyz-
er and data were analyzed using Genemapper software version 3.0
(Applied Biosystems).
9. Molecular karyotyping
The molecular karyotype was analyzed by SNP genotyping using
Illumina's HumanOmniExpressExome-8-v1.2 BeadArray (Illumina, Inc.,
San Diego, CA, USA) at the Institute for Human Genetics (Department of
Genomics, Life & Brain Center, University of Bonn, Germany). Processing
was performed on genomic DNA following the manufacturer's proce-
dures. LogR ratio and B allele plots were generated in GenomeStudio
V2011.1 (Illumina, Inc., San Diego, CA, USA) using the provided manifest
and cluster files version 1.2-B. Copy number regions were detected
using the cnvPartition version 3.1.6. A visual inspection had been
performed for mosaicism states.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2015.12.039.
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